ABBLO PHARMA ApS: Financial statements 2017
CVR: 34080534
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 119,645 and a net result of DKK -84,087 compared with DKK -379,981 the year before. Equity in the 2017 report amounted to DKK -1,240,853. The company had 1 employee in the financial year.
- Gross Profit
- DKK 119,645
- Profit/Loss
- DKK -84,087
- Equity
- DKK -1,240,853
- Total Assets
- DKK 560,443
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 120 t. | -84 t. | -1.2 mio. | 1 |
| 2016 | - | -217 t. | -380 t. | -1.2 mio. | 1 |
| 2014 | - | -126 t. | 2 mio. | -215 t. | - |
| 2013 | - | -12 t. | -2.7 mio. | -2.2 mio. | - |
Keep an eye on ABBLO PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ABBLO PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -216,678, and the net result was DKK -379,981.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.